Strategies in subversion: de‐regulation of the mammalian cell cycle by viral gene products

10.1091/mbc.3.6.655

Arvanitakis L., 1995, Latent membrane protein‐1 induces cyclin D2 expression, pRb hyperphosphorylation, and loss of TGF‐beta 1‐mediated growth inhibition in EBV‐positive B cells, J. Immunol., 155, 1047, 10.4049/jimmunol.155.3.1047

10.1128/jvi.70.4.2324-2331.1996

Boyer S.N., 1996, E7 protein of human papilloma virus‐16 induces degradation of retinoblastoma protein through the ubiquitin‐proteasome pathway, Cancer Res., 56, 4620

10.1038/35404

10.1093/emboj/18.9.2449

10.1006/viro.1996.0516

10.1006/viro.1997.8489

BresnahanW.A. ThompsonE.A. AlbrechtT.(1997b)Human cytomegalovirus infection results in altered Cdk2 subcellular localization.J Gen Virol 1993–1997.

10.1074/jbc.273.34.22075

10.1093/emboj/19.12.2877

10.1002/j.1460-2075.1996.tb00635.x

10.1074/jbc.271.50.31799

10.1038/382410a0

10.1128/JVI.74.11.5040-5052.2000

10.1073/pnas.92.12.5545

10.1128/MCB.17.4.2030

10.1093/jnci/89.24.1868

10.1128/MCB.20.10.3715-3727.2000

10.1099/0022-1317-80-3-549

10.1093/emboj/18.3.644

10.1016/S0092-8674(94)90522-3

10.1073/pnas.95.9.5281

10.1101/gad.11.16.2090

10.1016/0092-8674(91)90294-9

10.1126/science.7667636

10.1093/emboj/17.1.255

10.1016/0092-8674(91)90583-K

10.1128/jvi.71.6.4193-4198.1997

10.1038/nm0198-065

10.1038/342039a0

Hall M., 1995, Evidence for different modes of action of cyclin‐dependent kinase inhibitors: p15 and p16 bind to kinases, p21 and p27 bind to cyclins, Oncogene, 11, 1581

10.1038/371257a0

10.1126/science.7997877

10.1128/JVI.69.11.6705-6711.1995

10.1016/0962-8924(93)90150-Y

Hollyoake M., 1995, The normal cell cycle activation program is exploited during the infection of quiescent B lymphocytes by Epstein‐Barr virus, Cancer Res., 55, 4784

10.1038/387417a0

10.1128/jvi.69.11.6697-6704.1995

JohnsonR.A. YurochkoA.D. PomaE.E. ZhuL. HuangE.S.(1999) Domain mapping of the human cytomegalovirus IE1–72 and cellular p107 protein–protein interaction and the possible functional consequences.J. Gen. Virol.80 1293–303.

10.1101/gad.11.16.2101

10.1128/MCB.14.11.7235

10.1126/science.8475385

10.1002/j.1460-2075.1991.tb04897.x

10.1016/S0092-8674(00)81863-2

10.1074/jbc.273.14.8130

10.1016/S0959-437X(99)00045-3

10.1038/sj.onc.1202477

10.1074/jbc.273.36.23598

10.1016/S0955-0674(96)80080-9

10.1128/jvi.71.3.1984-1991.1997

Liu C., 1996, Activation of the Epstein‐Barr virus DNA polymerase promoter by the BRLF1 immediate‐early protein is mediated through USF and E2F, J. Virol., 70, 2545, 10.1128/jvi.70.4.2545-2555.1996

10.1128/JVI.71.3.1956-1962.1997

10.1128/MCB.18.2.753

10.1016/S0092-8674(00)80940-X

10.1073/pnas.96.2.382

10.1038/35410

10.1038/380262a0

10.1093/emboj/18.3.654

Martin L.G., 1998, Disruption of the G1/S transition in human papillomavirus type 16, E7–expressing human cells is associated with altered regulation of cyclin E, J Virol., 72, 975, 10.1128/JVI.72.2.975-985.1998

10.1128/JVI.74.9.4192-4206.2000

10.1016/S0168-9525(98)01408-5

Morozov A., 1997, Accumulation of human papillomavirus type 16, E7 protein bypasses G1 arrest induced by serum deprivation and by the cell cycle inhibitor p21, J Virol, 71, 3451, 10.1128/jvi.71.5.3451-3457.1997

10.1128/MCB.18.6.3620

10.1038/355362a0

10.1006/bbrc.1998.8950

Ojala P.M., 1999, Kaposi's sarcoma‐associated herpesvirus encoded V‐cyclin triggers apoptosis in cells with high levels of cyclin‐dependent kinase 6, Cancer Res., 59, 4984

10.1128/MCB.17.11.6459

10.1073/pnas.71.4.1286

Parker G.A., 1996, Epstein‐Barr virus nuclear antigen (EBNA) 3C is an immortalizing oncoprotein with similar properties to adenovirus E1A and papillomavirus E7, Oncogene, 13, 2541

10.1038/sj.onc.1203327

10.1016/0092-8674(94)90572-X

10.1101/gad.8.1.9

Poma E.E., 1996, The human cytomegalovirus IE1–72 protein interacts with the cellular p107 protein and relieves p107‐mediated trasncriptional repression of an E2F‐responsive promoter, J. Virol., 70, 7867, 10.1128/jvi.70.11.7867-7877.1996

10.1126/science.270.5233.90

10.1128/JVI.69.11.6859-6864.1995

10.1128/jvi.69.2.882-888.1995

Ruesch M.N., 1997, Initiation of DNA synthesis by human papillomavirus E7 oncoproteins is resistant to p21‐mediated inhibition of cyclin E‐cdk2 activity, J. Virol., 71, 5570, 10.1128/jvi.71.7.5570-5578.1997

10.1128/JVI.72.2.1005-1012.1998

10.1128/JVI.73.2.1438-1446.1999

Schulze A., 1998, Anchorage‐independent transcription of the cyclin A gene induced by the E7 oncoprotein of human papillomavirus type 16, J. Virol., 72, 2323, 10.1128/JVI.72.3.2323-2334.1998

10.1016/S0969-2126(99)80035-5

10.1128/MCB.19.2.1460

10.1126/science.274.5293.1672

10.1016/0092-8674(86)90390-9

10.1002/j.1460-2075.1994.tb06634.x

10.1126/science.7863328

Spitkovsky D., 1996, S‐phase induction by adenovirus E1A requires activation of cdc25a tyrosine phosphatase, Oncogene, 12, 2549

10.1002/j.1460-2075.1996.tb00505.x

10.1006/viro.1999.9760

10.1038/36606

10.1016/S0968-0004(99)01354-7

10.1073/pnas.90.12.5455

10.1146/annurev.bi.48.070179.001025

Vandyk L.F., 1999, The murine gammaherpesvirus 68 V‐cyclin gene is an oncogene that promotes cell cycle progression in primary lymphocytes, J. Virol., 73, 5110, 10.1128/JVI.73.6.5110-5122.1999

Van Kawaguchi Y.S.C., 1997, Herpes simplex virus 1 alpha regulatory protein ICP0 interacts with and stabilizes the cell cycle regulator cyclin D3, J. Virol., 71, 7328, 10.1128/jvi.71.10.7328-7336.1997

10.1073/pnas.96.14.8184

10.1128/MCB.11.8.4253

Zacny V.L., 1998, The Epstein‐Barr virus immediate early gene product, BRLF1, interacts with the retinoblastoma protein during the viral lytic cycle, J. Virol., 72, 8043, 10.1128/JVI.72.10.8043-8051.1998

10.1038/sj.onc.1202549

Zerfass K., 1995, Sequential activation of cyclin E and cyclin A gene expression by human papillomavirus type 16, E7 through sequences necessary for transformation, J Virol, 69, 6389, 10.1128/jvi.69.10.6389-6399.1995

Zerfass T.K., 1996, Inactivation of the cdk inhibitor p27KIP1 by the human papillomavirus type 16, E7 oncoprotein, Oncogene, 13, 2323

10.1016/S0092-8674(00)80625-X